ArticleCalcified tissue international2025
Multiscale Analysis Reveals Altered Characteristics in Femur and Mandible of Mice on a High Phosphate Diet.
Article in Calcified tissue international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Excessive phosphate used as flavor enhancers and preservatives in processed foods can exacerbate cardiovascular and kidney diseases. In clinical and pre-clinical studies, chronic (over 52 weeks) high-phosphate diet (HPD) negatively affects bone health. We previously demonstrated that 12-week-HPD decreases exercise capacity and skeletal muscle metabolism in adult male mice; however, alteration of bone characteristics associated with HPD independent of disease complications is not well-characterized. Thus, we determined the effects of shorter-term-HPD on characteristics of mouse femurs and mandibles. Adult male mice were fed a normal phosphate diet (NPD) or HPD for 18 weeks, serum markers of mineral metabolism and bone formation and resorption were quantified in femurs, and histological analysis was performed on tibias. Volumetric, mineral density, and morphology parameters of femurs and mandibles were determined using micro-computed tomography, and dynamic mechanical analysis and fracture testing of the femur were conducted. Our studies revealed that 18-week-HPD significantly reduced bone quality (tissue mineral density (TMD) and cortical thickness) without changing bone quantity (total mineral content and volume) of both femurs and mandibles, and femur mechanical properties were aggravated increasing the risk of fracture. Serum markers of osteoclastic resorption and osteoblastic formation were increased with HPD, indicating active osteoclastic bone resorption and osteoblastic new bone formation. These findings provide detailed information on how excessive dietary phosphate substantially alters characteristics of bone, resulting in bone weakening.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.